Computer aided epitope design as a peptide vaccine component against Lassa virus.
Bioinformation 2017;
13:417-429. [PMID:
29379262 PMCID:
PMC5767920 DOI:
10.6026/97320630013417]
[Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2017] [Revised: 12/05/2017] [Accepted: 12/05/2017] [Indexed: 12/16/2022] Open
Abstract
Lassa virus (LASV) is an arena virus causing hemorrhagic fever and it is endemic in several regions of West Africa. The disease-causing
virus records high mortality rate in endemic regions due to lack of appropriate treatment and prevention strategies. Therefore, it is of
interest to design and develop viable vaccine components against the virus. We used the Lassa virus envelope glyco-proteins as a
vaccine target to identify linear peptides as potential epitopes with immunogenic properties by computer aided epitope prediction
tools. We report a T-cell epitope 'LLGTFTWTL' and a B-cell epitope 'AELKCFGNTAVAKCNE' with predicted potential
immunogenicity for further in vivo and in vitro consideration.
Collapse